Medical device manufacturer SunMed today completed the acquisition of Vyaire Medical’s business unit that manufactures and markets respiratory and anesthesia consumables. SunMed itself is specialized in consumables for anesthesia and respiratory care, and the combination with the Vyaire business will make it a "one-stop source" for practitioners seeking those products. The terms of the acquisition were not disclosed.
SunMed is headquartered in Grand Rapids, MI, and operates six FDA-registered and ISO 13485–certified manufacturing plants in Tucson, AZ; Mexico; and China. Capabilities include injection, compression, blow, and dip molding; molding tool design, build, and validation; and extrusion. ISO Class 7 and Class 8 cleanrooms are on site.
Chicago-based Vyaire was launched in 2016 via a joint venture between Becton Dickinson & Co. (BD) and private equity firm Apax Partners. In 2018, BD divested its minority share in Vyaire to Apax Partners in a deal estimated at $435 million.
SunMed CEO Hank Struik made note of the promising opportunities ahead for the joined brands. “As we bring our people together, we are confident in the highly complementary nature of our platforms and in our ability to strengthen our manufacturing capabilities and ensure our customers reliable and predictable supply of the most trusted respiratory and anesthesia consumables,” said Struik in a prepared statement. “Together, we will be even better positioned to drive innovation, using our combined expertise and industry-leading engineering capabilities. Our mission will continue to be focused on improving quality of life and setting the standard of care.”